International audienceObjective: The treatment of hypothalamus-invading craniopharyngiomas, based on pediatric experience, is subtotal resection (STR) with radiotherapy. This strategy sometimes leads to uncontrollable tumor progression. In adults, with the use of endoscopic endonasal surgery (EES), does removing the hypothalamic part of the tumor-whenever possible-compromise the outcome of the patients?Methods: We included adults with craniopharyngioma treated by a first EES in 2008-2016 by senior neurosurgeon (E.J.). Endocrine, ophthalmologic, and hypothalamic data were retrospectively collected, including body mass index (BMI), cognitive and social status, with a systematic follow-up interview. Magnetic resonance imaging scans were graded...
Object. Craniopharyngioma accounts for 2%-5% of all primary intracranial neoplasms. The optimal mana...
International audienceCraniopharyngiomas (CPs) are rare tumors of the skull base, developing near th...
Hypothalamic obesity is an major concern in children treated for craniopharyngioma. Not only the cra...
International audienceObjective: The treatment of hypothalamus-invading craniopharyngiomas, based on...
Objective: The optimal surgical strategy for management of adult patients with craniopharyngioma rem...
Craniopharyngioma (CP) is a histologically benign tumor with high mortality and morbidity. Although ...
Objective: Although craniopharyngiomas are benign pathologies, they have surgical challenges due to ...
Background: Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (...
BACKGROUND: Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (...
Craniopharyngiomas are biologically benign lesions (WHO Grade 1) of the sellar and suprasellar regio...
BackgroundHypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (CP...
Craniopharyngiomas are slow growing benign tumors of the sellar and parasellar region with an overal...
Background: Craniopharyngioma (CP) is a rare brain tumor involving the sellar region. The best manag...
Context: Craniopharyngioma is a rare neoplastic entity of the central nervous system. Childhood-onse...
Object. Craniopharyngioma accounts for 2%-5% of all primary intracranial neoplasms. The optimal mana...
International audienceCraniopharyngiomas (CPs) are rare tumors of the skull base, developing near th...
Hypothalamic obesity is an major concern in children treated for craniopharyngioma. Not only the cra...
International audienceObjective: The treatment of hypothalamus-invading craniopharyngiomas, based on...
Objective: The optimal surgical strategy for management of adult patients with craniopharyngioma rem...
Craniopharyngioma (CP) is a histologically benign tumor with high mortality and morbidity. Although ...
Objective: Although craniopharyngiomas are benign pathologies, they have surgical challenges due to ...
Background: Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (...
BACKGROUND: Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (...
Craniopharyngiomas are biologically benign lesions (WHO Grade 1) of the sellar and suprasellar regio...
BackgroundHypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (CP...
Craniopharyngiomas are slow growing benign tumors of the sellar and parasellar region with an overal...
Background: Craniopharyngioma (CP) is a rare brain tumor involving the sellar region. The best manag...
Context: Craniopharyngioma is a rare neoplastic entity of the central nervous system. Childhood-onse...
Object. Craniopharyngioma accounts for 2%-5% of all primary intracranial neoplasms. The optimal mana...
International audienceCraniopharyngiomas (CPs) are rare tumors of the skull base, developing near th...
Hypothalamic obesity is an major concern in children treated for craniopharyngioma. Not only the cra...